Monsanto Company in December announced the commercialization of its new Bollgard® 3 XtendFlex® cotton technology, the first commercial cotton product ever with full federal approvals for the trait and in-crop herbicide system to combine three modes of action for both lepidopteran insect control and herbicide tolerance.
The introduction of Bollgard 3 XtendFlex technology marks a major milestone for innovation in cotton, giving growers access to best-in-class germplasm while providing enhanced, seasonlong protection against damage caused by key lepidopteran pests, and the ability for in-crop use of dicamba.
Bollgard 3 XtendFlex technology is built on the proven and effective success of its predecessors. Containing a third protein, Vip3A, that provides a third mode of action in addition to the Cry1Ac and Cry2Ab Bt proteins found in Genuity® Bollgard II® technology. The introduction provides three unique proteins and modes of action, helping provide better insect control while increasing the longevity of the technology.
“This product has been highly anticipated by growers, and we are excited to bring Bollgard 3 XtendFlex technology to the marketplace,” said Jessie Christiansen, Monsanto Cotton Team Lead. “This launch is the latest example of Monsanto’s continuing commitment to bringing new and innovative cotton products through our pipeline, offering new benefits and solutions to growers that feature elite germplasm and enhanced protection against key pests – including armyworms and bollworms – that will enable them to produce the best crop possible.”
A limited release of Bollgard 3 XtendFlex to select NPE growers is planned in 2017, with a full-scale launch planned for 2018.